Exacerbations Among Patients Receiving Breztri (EROS Study)

Clinical trial NCT06514144 · COMPLETED

Trial details

NCT number: NCT06514144
Sponsor: AstraZeneca
Status: COMPLETED
Study type: OBSERVATIONAL

Pulmonary Disease Chronic Obstructive Retrospective Studies

Start date: 2022-10-01
Primary completion: 2023-03-07
Enrollment: 2409

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.